Community respiratory virus infections in immunocompromised patients with cancer.
about
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsFourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusReal-time PCR in clinical microbiology: applications for routine laboratory testing.Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveHigh prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assaysRespiratory syncytial virus infection in adultsNosocomial spread of viral diseaseIdentification of adenovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia.Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended.Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.Identification of new respiratory viruses in the new millennium.Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?Influenza-associated morbidity in children with cancer.Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignanciesMolecular genetic methods in the diagnosis of lower respiratory tract infections.Management of respiratory viral infections in hematopoietic cell transplant recipients.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationRespiratory virus shedding in a cohort of on-duty healthcare workers undergoing prospective surveillance.Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.Impact of parainfluenza virus infection in pediatric cancer patients.Infection prevention in the cancer center.Antiviral effect of Saccharomyces cerevisiae beta-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide.A survey strategy for human respiratory syncytial virus detection among haematopoietic stem cell transplant patients: epidemiological and methodological analysis.Low mortality rates related to respiratory virus infections after bone marrow transplantation.Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR.Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection.Epidemiologic Analysis of Respiratory Viral Infections Mainly in Hospitalized Children and Adults in a Midwest University Medical Center After the Implementation of a 14-Virus Multiplex Nucleic Acid Amplification Test.Respiratory syncytial virus infections in previously healthy working adults.BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Report on influenza A and B viruses: their coinfection in a Saudi leukemia patient.Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center stuPre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.Respiratory Syncytial Virus Infection Control Challenges with a Novel Polymerase Chain Reaction Assay in a Tertiary Medical Center.
P2860
Q26829188-734F3461-8261-41FB-A7BE-F20C4A98D592Q27021622-7807468D-125D-4695-B112-BA333B050C14Q27472851-B2735351-8216-4F39-A63A-A197EE867890Q28178690-E33C97E1-7763-42EB-A6CD-ED5C7FA66C2AQ28388806-C2681FBF-2ABD-467A-A925-0D84FE64B528Q33592272-BB70FF1A-498C-4F00-81A8-BEDF62932027Q33961877-8B30871E-67D1-4399-95DB-7B1CFD8552C2Q33975722-AF31EB65-D228-4C02-8922-0D6A73B656EDQ34015110-56EE5A2F-0716-4DD0-AA0A-61C6E2C34F4EQ34033632-BDFCDD71-EFB9-4B94-AB27-6CE6C70AE21DQ34299730-B7A2DC0D-C5E8-4D91-8985-542008D6CCF6Q35232791-2C5B16A5-0762-405A-A516-35B0DD66662BQ35526996-491CDCEF-7344-497F-9F71-2A475FBF3B2DQ35879581-AFEC9FC4-19C9-48B3-9FF7-21C1E8FB9E7FQ35922572-9A76108E-EA05-4534-BD46-40382138AB5CQ35945742-650FDD3B-DA44-4F63-BD66-D57D0CFB35DAQ36003045-427CC809-331B-4A5C-B63F-7A43CA813A34Q36439896-6EAE3955-5358-4C4D-9947-C61589C3FA6FQ36965855-95EA66D5-720D-4327-83AB-DA23D7DF58DEQ37061644-B01E0A9A-6526-46CA-B07F-CF3CA1D7D241Q37284406-50F56BB2-3300-4B41-8B70-ACE7B5B5B526Q37957824-BC3E9483-FAD0-429D-93B7-5AC3C43B5D7CQ38104929-0ADE6221-EF16-4F0A-AF85-AC75D19FF047Q38517976-949EDE4A-6D61-4F8E-B5B9-94AC470C8D92Q38602664-161A2D4A-C2DC-4F44-AC2A-F21B7CFC06AFQ39199992-D7869272-4057-4197-9BF3-216B28853B7DQ39751003-7F5275DF-D9C3-4159-BBA3-150F3382E299Q40104785-9AFDDF48-BE8D-4ACC-98FB-1DA91B296159Q40393664-CC22C424-DF02-4BBD-B46C-1D27969E7AD3Q40597674-C7C51CA0-63A5-4C9C-BA70-D9AF8BE48A03Q40721939-623DBAC7-31CB-4AA9-999E-B4205928553FQ42094332-B6B2B290-F986-421E-93CF-5557B7B55722Q43407951-C827DFA7-B394-4043-9C2E-12A472A024E6Q43577899-C58BB679-A1E5-4FF7-9399-EF111FDAD107Q43645374-6BE46DCA-7DB4-449C-911C-82054FBE1DEAQ43848095-4EDD3418-A517-4684-9693-B20F4338F54EQ44148387-2CEBD811-8A30-4948-A5C5-37660BAF2702Q44923546-7903F8F6-A199-4965-9BCE-BA7A613F815DQ45070426-C727B7ED-A6EE-4FF6-BF8C-198C32ABCA71Q45325899-4D1E0D43-9CD7-4061-B914-BF8649DC97FB
P2860
Community respiratory virus infections in immunocompromised patients with cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Community respiratory virus infections in immunocompromised patients with cancer.
@ast
Community respiratory virus infections in immunocompromised patients with cancer.
@en
type
label
Community respiratory virus infections in immunocompromised patients with cancer.
@ast
Community respiratory virus infections in immunocompromised patients with cancer.
@en
prefLabel
Community respiratory virus infections in immunocompromised patients with cancer.
@ast
Community respiratory virus infections in immunocompromised patients with cancer.
@en
P2093
P1476
Community respiratory virus infections in immunocompromised patients with cancer.
@en
P2093
P304
10-8; discussion 25-6
P356
10.1016/S0002-9343(97)80004-6
P407
P577
1997-03-01T00:00:00Z